Monopar Therapeutics (MNPR) Misses Q3 EPS by 48c
Tweet
Share
E-mailGet Alerts MNPR Hot Sheet
Join SI Premium – FREE
Monopar Therapeutics (NASDAQ: MNPR) reported Q3 EPS of ($0.48).
For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy rejects short-seller report on finances and supply chain
- Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
- Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
